Dyadic International up on expanded vaccine deal for African markets

Dyadic International

12/04/2023 14:06

** Shares of biotech co Dyadic International Inc  DYAI.O  up
2.1% at $1.96 premarket
    ** Co expands licensing agreement with Rubic One Health, a
South Africa-based vaccine consortium 
    ** Cos had a prior agreement to develop and manufacture
COVID-19 vaccines in under-served African markets
    ** Renewed agreement to include vaccines and therapeutic
proteins beyond COVID-19 for both human and animal health
markets
    ** DYAI will receive some marketing rights and other
considerations, including milestones and royalty payments, from
Rubic
    ** Stock up 56% YTD

 (Reporting by Aditya Samal)
 ((Aditya.Samal@thomsonreuters.com;))